Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

Moore JO, George SL, Dodge RK, Amrein PC, Powell BL, Kolitz JE, Baer MR, Davey FR, Bloomfield CD, Larson RA, Schiffer CA.

Blood. 2005 May 1;105(9):3420-7. Epub 2004 Nov 30.

2.

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.

Kolitz JE, George SL, Dodge RK, Hurd DD, Powell BL, Allen SL, Velez-Garcia E, Moore JO, Shea TC, Hoke E, Caligiuri MA, Vardiman JW, Bloomfield CD, Larson RA; Cancer and Leukemia Group B.

J Clin Oncol. 2004 Nov 1;22(21):4290-301.

PMID:
15514371
3.

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.

Sekeres MA, Peterson B, Dodge RK, Mayer RJ, Moore JO, Lee EJ, Kolitz J, Baer MR, Schiffer CA, Carroll AJ, Vardiman JW, Davey FR, Bloomfield CD, Larson RA, Stone RM; Cancer and Leukemia Group B.

Blood. 2004 Jun 1;103(11):4036-42. Epub 2004 Feb 19.

PMID:
14976037
4.

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.

Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT.

Lancet. 2004 Feb 14;363(9408):535-6.

PMID:
14975618
5.

Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.

Wetzler M, Dodge RK, Mrózek K, Stewart CC, Carroll AJ, Tantravahi R, Vardiman JW, Larson RA, Bloomfield CD.

Br J Haematol. 2004 Feb;124(3):275-88.

PMID:
14717774
6.

Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995).

Williams LE, Gliatto JM, Dodge RK, Johnson JL, Gamblin RM, Thamm DH, Lana SE, Szymkowski M, Moore AS; Veterinary Cooperative Oncology Group.

J Am Vet Med Assoc. 2003 Sep 15;223(6):825-31.

PMID:
14507100
7.

A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation.

Proulx DR, Ruslander DM, Dodge RK, Hauck ML, Williams LE, Horn B, Price GS, Thrall DE.

Vet Radiol Ultrasound. 2003 May-Jun;44(3):352-9.

PMID:
12816381
8.

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

Szatrowski TP, Dodge RK, Reynolds C, Westbrook CA, Frankel SR, Sklar J, Stewart CC, Hurd DD, Kolitz JE, Velez-Garcia E, Stone RM, Bloomfield CD, Schiffer CA, Larson RA.

Cancer. 2003 Mar 15;97(6):1471-80.

9.

Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression.

Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL.

Obstet Gynecol. 2003 Jan;101(1):157-63.

PMID:
12517661
10.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PR, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD; Cancer and Leukemia Group B (CALGB 8461).

Blood. 2002 Dec 15;100(13):4325-36. Epub 2002 Aug 1.

PMID:
12393746
11.

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.

Farag SS, George SL, Lee EJ, Baer M, Dodge RK, Becknell B, Fehniger TA, Silverman LR, Crawford J, Bloomfield CD, Larson RA, Schiffer CA, Caligiuri MA.

Clin Cancer Res. 2002 Sep;8(9):2812-9. Erratum in: Clin Cancer Res. 2002 Nov;8(11):3639.

12.

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

Baer MR, George SL, Dodge RK, O'Loughlin KL, Minderman H, Caligiuri MA, Anastasi J, Powell BL, Kolitz JE, Schiffer CA, Bloomfield CD, Larson RA.

Blood. 2002 Aug 15;100(4):1224-32.

PMID:
12149202
13.

Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy.

Kang SK, Chou RH, Dodge RK, Clough RW, Kang HS, Hahn CA, Whitehurst AW, Buckley NJ, Kim JH, Joyner RE, Montana GS, Ingram SS, Anscher MS.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):99-103.

PMID:
12007947
14.

Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta.

Rodriguez GC, Nagarsheth NP, Lee KL, Bentley RC, Walmer DK, Cline M, Whitaker RS, Isner P, Berchuck A, Dodge RK, Hughes CL.

J Natl Cancer Inst. 2002 Jan 2;94(1):50-60.

PMID:
11773282
15.

Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.

Alvarez AA, Axelrod JR, Whitaker RS, Isner PD, Bentley RC, Dodge RK, Rodriguez GC.

Gynecol Oncol. 2001 Aug;82(2):273-8.

PMID:
11531279
16.

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, Lee EJ, Moore JO, Powell BL, Baer MR, Bloomfield CD, Schiffer CA.

Blood. 2001 Aug 1;98(3):548-53.

PMID:
11468148
17.

Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.

Kang SK, Chou RH, Dodge RK, Clough RW, Kang HL, Bowen MG, Steffey BA, Das SK, Zhou SM, Whitehurst AW, Buckley NJ, Kim JH, Joyner RE, Sarmina I, Montana GS, Ingram SS, Anscher MS.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):937-45.

PMID:
11429221
18.

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).

Baer MR, Stewart CC, Dodge RK, Leget G, Sulé N, Mrózek K, Schiffer CA, Powell BL, Kolitz JE, Moore JO, Stone RM, Davey FR, Carroll AJ, Larson RA, Bloomfield CD.

Blood. 2001 Jun 1;97(11):3574-80.

PMID:
11369653
19.

Significance of lymphoglandular bodies in bone marrow aspiration smears.

Stern RC, Liu K, Dodge RK, Elenitoba-Johnson KS, Layfield LJ.

Diagn Cytopathol. 2001 Apr;24(4):240-3.

PMID:
11285618
20.

Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.

Elconin JH, Roberts KB, Rizzieri DA, Vermont C, Clough RW, Kim C, Dodge RK, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1097-105.

PMID:
11072168
21.

Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.

Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, Berchuck A.

Clin Cancer Res. 2000 Aug;6(8):2999-3005.

22.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
23.

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome.

Brizel DM, Dodge RK, Clough RW, Dewhirst MW.

Radiother Oncol. 1999 Nov;53(2):113-7.

PMID:
10665787
24.

Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients.

Liu K, Marshall J, Shaw HS, Dodge RK, Layfield LJ.

Acta Cytol. 1999 Nov-Dec;43(6):1027-33.

PMID:
10578974
25.

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.

Byrd JC, Dodge RK, Carroll A, Baer MR, Edwards C, Stamberg J, Qumsiyeh M, Moore JO, Mayer RJ, Davey F, Schiffer CA, Bloomfield CD.

J Clin Oncol. 1999 Dec;17(12):3767-75.

PMID:
10577848
26.

The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy.

Prosnitz LR, Maguire P, Anderson JM, Scully SP, Harrelson JM, Jones EL, Dewhirst M, Samulski TV, Powers BE, Rosner GL, Dodge RK, Layfield L, Clough R, Brizel DM.

Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):941-9.

PMID:
10571201
28.

Palliative radiotherapy of appendicular osteosarcoma in 95 dogs.

Ramirez O 3rd, Dodge RK, Page RL, Price GS, Hauck ML, LaDue TA, Nutter F, Thrall DE.

Vet Radiol Ultrasound. 1999 Sep-Oct;40(5):517-22.

PMID:
10528848
29.

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 1999 Sep;74(3):385-94.

PMID:
10479498
30.

Logistic regression analysis of high grade spindle cell neoplasms. A fine needle aspiration cytologic study.

Liu K, Dodge RK, Layfield LJ.

Acta Cytol. 1999 Jul-Aug;43(4):593-600.

PMID:
10432880
31.

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.

Wetzler M, Dodge RK, Mrózek K, Carroll AJ, Tantravahi R, Block AW, Pettenati MJ, Le Beau MM, Frankel SR, Stewart CC, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD.

Blood. 1999 Jun 1;93(11):3983-93.

PMID:
10339508
32.

Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Davey FR, Powell BL, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD.

Blood. 1999 Jun 1;93(11):3931-9.

PMID:
10339502
33.

Logistic regression analysis of small round cell neoplasms: a cytologic study.

Layfield LJ, Liu K, Dodge RK.

Diagn Cytopathol. 1999 May;20(5):271-7.

PMID:
10319227
34.

Diagnostic accuracy in fine-needle aspiration of soft tissue and bone lesions. Influence of clinical history and experience.

Liu K, Layfield LJ, Coogan AC, Ballo MS, Bentz JS, Dodge RK.

Am J Clin Pathol. 1999 May;111(5):632-40.

PMID:
10230353
35.

The prognostic significance of angiogenesis in epithelial ovarian carcinoma.

Alvarez AA, Krigman HR, Whitaker RS, Dodge RK, Rodriguez GC.

Clin Cancer Res. 1999 Mar;5(3):587-91.

36.

Logistic regression analysis of low grade spindle cell lesions. A cytologic study.

Liu K, Dodge RK, Dodd LG, Layfield LJ.

Acta Cytol. 1999 Mar-Apr;43(2):143-52.

PMID:
10097701
37.

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

Risinger JI, Hayes K, Maxwell GL, Carney ME, Dodge RK, Barrett JC, Berchuck A.

Clin Cancer Res. 1998 Dec;4(12):3005-10.

38.

Logistic regression analysis of myxoid sarcomas: a cytologic study.

Layfield LJ, Liu K, Dodge RK.

Diagn Cytopathol. 1998 Nov;19(5):355-60.

PMID:
9812230
39.

In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformans.

Schell WA, De Almeida GM, Dodge RK, Okonogi K, Perfect JR.

Antimicrob Agents Chemother. 1998 Oct;42(10):2630-2.

40.

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA.

Blood. 1998 Sep 1;92(5):1556-64.

PMID:
9716583
41.
42.

Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.

Scher RL, Saito W, Dodge RK, Richtsmeier WJ, Fine RL.

Otolaryngol Head Neck Surg. 1998 Apr;118(4):464-71.

PMID:
9560096
43.

Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation.

Acker JC, Marks LB, Spencer DP, Yang W, Avery MA, Dodge RK, Rosner GL, Dewhirst MW.

Radiat Res. 1998 Apr;149(4):350-9.

PMID:
9525499
44.

Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.

Layfield LJ, Saria EA, Berchuck A, Dodge RK, Thompson JK, Conlon DH, Kerns BJ.

J Surg Oncol. 1997 Dec;66(4):230-6; discussion 236-7.

PMID:
9425325
45.

Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.

Brizel DM, Hage WD, Dodge RK, Munley MT, Piantadosi CA, Dewhirst MW.

Radiat Res. 1997 Jun;147(6):715-20.

PMID:
9189170
46.

A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure.

Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR.

Int J Hyperthermia. 1997 May-Jun;13(3):307-16.

PMID:
9222813
47.

Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters.

Dodd LG, Kerns BJ, Dodge RK, Layfield LJ.

J Surg Oncol. 1997 Apr;64(4):280-7; discussion 287-8.

PMID:
9142183
49.

Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure.

Hahn JS, Braun RD, Dewhirst MW, Shan S, Snyder SA, Taube JM, Ong ET, Rosner GL, Dodge RK, Bonaventura J, Bonaventura C, DeAngelo J, Meyer RE.

Radiat Res. 1997 Feb;147(2):185-94.

PMID:
9008211
50.

Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas.

Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Dodge RK, Charles HC, Samulski TV, Prosnitz LR, Dewhirst MW.

Cancer Res. 1996 Dec 1;56(23):5347-50.

Supplemental Content

Loading ...
Support Center